CURRIE MARK G (Chief Scientific Officer) received a stock award from IRONWOOD PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/12/2025ACC: 0000950170-25-085440
Officer· Chief Scientific Officer
Since Jul 2018
+45K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
45K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+45K
Price / share
—
Trade value
—
% of position
7.9%
6/10/2025
568.42K→613.42K
Total
Net shares
+45K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/10/2025 | A · Award | +45K | — | — | 7.9% | 568.42K | 613.42K |
| Total | +45K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported